0.3376
8.76%
-0.0324
Finanzdaten der Tonix Pharmaceuticals Holding Corp-Aktie (TNXP)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
34.32%
2.482
|
3.779 | 3.989 | - | - |
Operating Expenses
|
23.39%
23.83
|
31.11 | 32.14 | - | - |
Benefits Costs and Expenses |
24.57%
26.32
|
34.89 | 36.12 | - | - |
Costs And Expenses |
23.39%
23.83
|
31.11 | 32.14 | 29.00 | 33.90 |
Depreciation and Amortization |
0.00%
1.00
|
1.00 | 0.978 | - | - |
Operating Income/Loss |
21.87%
-21.35
|
-27.33 | -28.15 | -29.00 | -33.90 |
Income/Loss From Continuing Operations Before Tax |
23.39%
-23.83
|
-31.11 | -32.14 | -28.36 | -33.01 |
Income/Loss From Continuing Operations After Tax |
45.32%
-14.94
|
-27.32 | -27.98 | -28.36 | -33.01 |
Net Income/Loss
|
45.32%
-14.94
|
-27.32 | -27.98 | -28.36 | -33.01 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
1,531%
80.88
|
4.9597 | 15.33 | 10.59 | 63.35 |
Diluted Average Shares |
1,531%
80.88
|
4.9597 | 15.33 | 10.59 | 63.35 |
Basic Earnings Per Share |
132.73%
-0.18
|
0.55 | -1.83 | -2.68 | -0.52 |
Diluted Earnings Per Share |
132.73%
-0.18
|
0.55 | -1.83 | -2.68 | -0.52 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):